Publications
Genentech scientists are encouraged to be creative and active members of the scientific community. We are proud of our publication record in Science, Nature, Cell, and other prestigious peer-reviewed journals, where our annual output consistently rivals or surpasses that of the top academic institutions.
|
CPT: Pharmacometrics and Systems Pharmacology, ISSN: 21638306
|
|
Nature Medicine, ISSN: 1546170X 10788956
|
|
PLoS ONE, ISSN: 19326203
|
|
CD96 functions as a co-stimulatory receptor to enhance CD8+ T cell activation and effector responses
European Journal of Immunology, ISSN: 15214141 00142980
|
|
Current Opinion in Immunology, ISSN: 18790372 09527915
|
|
Science Signaling, ISSN: 19379145 19450877
|
|
It Takes Two to Regenerate: Optimizing Custom Wnt Surrogates
Cell Chemical Biology, ISSN: 24519456
|
|
Frontiers in Cell and Developmental Biology, ISSN: 2296634X
|
|
Analytical Chemistry, ISSN: 15206882 00032700
|
|
Analytical Chemistry, ISSN: 15206882 00032700
|
|
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
The Lancet, ISSN: 01406736
|
|
Clinical Cancer Research, ISSN: 15573265 10780432
|
|
Proceedings of the National Academy of Sciences of the United States of America, ISSN: 10916490 00278424
|
|
Proceedings of the National Academy of Sciences of the United States of America, ISSN: 10916490 00278424
|
|
Expert Opinion on Therapeutic Targets, ISSN: 17447631 14728222
|
|
Molecular and Cellular Oncology, ISSN: 23723556
|
|
Toxicological Sciences, ISSN: 10960929
|
|
Drug Metabolism and Disposition, ISSN: 1521009X
|
|
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Nature Medicine,
|
|
IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation
Future Oncology,
|
|
Journal of Clinical Investigation, ISSN: 15588238 00219738
|
|
American Health and Drug Benefits, ISSN: 19422970 19422962
|
|
Cancer Chemotherapy and Pharmacology, ISSN: 14320843 03445704
|
|
Lupus, ISSN: 14770962 09612033
|
|
Lancet Neurology, ISSN: 14744465 14744422
|
|
Pharmaceutical Research, ISSN: 1573904X 07248741
|
|
PLoS ONE, ISSN: 19326203
|
|
eLife, ISSN: 2050084X
|
|
Cell, ISSN: 10974172 00928674
|
|
Annual Review of Immunology, ISSN: 15453278 07320582
|
|
Science Translational Medicine, ISSN: 19466242 19466234
|
|
Journal of Pharmaceutical and Biomedical Analysis, ISSN: 1873264X 07317085
|
|
Clinical Cancer Research, ISSN: 15573265 10780432
|
|
Cancer Research, ISSN: 15387445 00085472
|
|
Immunity, ISSN: 10974180 10747613
|
|
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody
JCI insight, ISSN: 23793708
|
|
ACS Medicinal Chemistry Letters, ISSN: 19485875
|
|
Journal of Experimental Medicine, ISSN: 15409538
|
|
Journal of Proteome Research, ISSN: 15353907 15353893
|
|
Drug Metabolism Reviews, ISSN: 10979883 03602532
|
|
Molecular Cancer Therapeutics, ISSN: 15388514
|
|
Molecular Cancer Research, ISSN: 15573125 15417786
|
|
The Lancet Oncology, ISSN: 14745488 14702045
|
|
Diabetologia, ISSN: 14320428 0012186X
|
|
Ophthalmic Surgery Lasers and Imaging, ISSN: 19382375 15428877
|
|
Annals of Oncology, ISSN: 15698041 09237534
|
|
Trends in Cell Biology, ISSN: 18793088 09628924
|
|
Pharmacology Research and Perspectives, ISSN: 20521707
|
|
Lymph node stromal cells: cartographers of the immune system
Nature Immunology, ISSN: 15292908
|
|
Magnesium-Catalyzed N 2-Regioselective Alkylation of 3-Substituted Pyrazoles
Synlett, ISSN: 09365214
|
